Adams J - Search Results

1

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE. Adams J, et al. Cancer Res. 2000 Jun 1;60(11):2898-905. Cancer Res. 2000. PMID: 10850435

2

A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation.

Joffe JK, Banks RE, Forbes MA, Hallam S, Jenkins A, Patel PM, Hall GD, Velikova G, Adams J, Crossley A, Johnson PW, Whicher JT, Selby PJ. Joffe JK, et al. Among authors: adams j. Br J Urol. 1996 May;77(5):638-49. doi: 10.1046/j.1464-410x.1996.09573.x. Br J Urol. 1996. PMID: 8689103 Clinical Trial.

3

Patient experiences of continuity of cancer care: development of a new medical care questionnaire (MCQ) for oncology outpatients.

Harley C, Adams J, Booth L, Selby P, Brown J, Velikova G. Harley C, et al. Among authors: adams j. Value Health. 2009 Nov-Dec;12(8):1180-6. doi: 10.1111/j.1524-4733.2009.00574.x. Epub 2009 Jul 29. Value Health. 2009. PMID: 19659706 Free article.

4

Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.

Adams J, Williams SV, Aveyard JS, Knowles MA. Adams J, et al. Cancer Res. 2005 Jan 1;65(1):66-75. Cancer Res. 2005. PMID: 15665280

5

Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity.

Adams J, Cuthbert-Heavens D, Bass S, Knowles MA. Adams J, et al. Cancer Lett. 2005 Apr 8;220(2):137-44. doi: 10.1016/j.canlet.2004.06.052. Cancer Lett. 2005. PMID: 15766588

6

Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.

Williams SV, Adams J, Coulter J, Summersgill BM, Shipley J, Knowles MA. Williams SV, et al. Among authors: adams j. Genes Chromosomes Cancer. 2005 Aug;43(4):315-28. doi: 10.1002/gcc.20166. Genes Chromosomes Cancer. 2005. PMID: 15846775

7

Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: a well-tolerated combination.

Nichols RC Jr, Sweetser MG, Mahmood SK, Malamud FC, Dunn NP, Adams JP, Kyker JS, Lydick K. Nichols RC Jr, et al. Among authors: adams jp. Int J Cancer. 2000 Oct 20;90(5):281-6. Int J Cancer. 2000. PMID: 11091352

8

Proton Beam Therapy for Advanced Periocular Skin Cancer: An Eye-Sparing Approach.

Zhang Y, Lima ICS, Woo AA, Zieminski S, Adams JA, Hughes MA, Chan AW. Zhang Y, et al. Among authors: adams ja. Cancers (Basel). 2025 Jan 20;17(2):327. doi: 10.3390/cancers17020327. Cancers (Basel). 2025. PMID: 39858108

9

SSTR2-Targeted Theranostics in Hepatocellular Carcinoma.

Momeny M, AghaAmiri S, Hernandez Vargas S, Acidi B, Ghosh SC, Bateman TM, Adams JT, Khalaj V, Kaseb AO, Tran Cao HS, Azhdarinia A. Momeny M, et al. Among authors: adams jt. Cancers (Basel). 2025 Jan 7;17(2):162. doi: 10.3390/cancers17020162. Cancers (Basel). 2025. PMID: 39857944

10

Rapid human oogonia-like cell specification via transcription factor-directed differentiation.

Pierson Smela M, Kramme CC, Fortuna PRJ, Wolf B, Goel S, Adams J, Ma C, Velychko S, Widocki U, Srikar Kavirayuni V, Chen T, Vincoff S, Dong E, Kohman RE, Kobayashi M, Shioda T, Church GM, Chatterjee P. Pierson Smela M, et al. Among authors: adams j. EMBO Rep. 2025 Jan 23. doi: 10.1038/s44319-025-00371-2. Online ahead of print. EMBO Rep. 2025. PMID: 39849206 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,038 results

Search Page

Filters